Real-World Health and Economic Effects of a Large-Scale Outpatient Screening and Continuing Care Programme for Early Detection and Care of Microvascular Complications in Patients with Type 2 Diabetes Implemented in Routine Care Across Germany: A Quasi-Experimental Study Using Health Insurance Claims Data [0.03%]
德国一项大型门诊筛查和连续护理计划在常规医疗保健中的真实世界健康和经济效益评价：使用健康保险索赔数据进行准实验研究，以早期发现和治疗2型糖尿病患者的微血管并发症
Min Fan,Anna-Janina Stephan,Michael Hanselmann et al.
Min Fan et al.
Aim: The aim of this study was to analyse the real-world health and economic effect of an outpatient screening and continuing-care programme for early detection and care of microvascular complications in patients with typ...
Discrete Event Simulation in R using the 'Simmer' Package for Health Economic Modelling: A Tutorial and Illustration in Colon Cancer [0.03%]
基于R中的“Simmer”包的离散事件仿真在健康经济模型中的应用——结直肠癌为例
Koen Degeling,Jonathan Karnon,Michiel van de Ven et al.
Koen Degeling et al.
Discrete event simulation (DES) provides enhanced flexibility over modelling techniques that have been traditionally used for assessing health-economic outcomes, making it a particularly interesting technique for modelling complex clinical ...
Cost-Effectiveness of a Universal School-Based Mental Health Prevention Program: An Economic Modeling Study in a Limited Income Context [0.03%]
一项普遍学校心理健康预防项目的成本效益研究：有限收入背景下基于经济学的模型研究
Ha T Nguyen,Anh Q Nguyen,Nga T Nguyen et al.
Ha T Nguyen et al.
Objective: This study aims to evaluate the cost-effectiveness of a school-based mental health prevention program in a limited income context to inform investment decisions. ...
Selection and Prioritization of Medical Devices for HTA Evaluation: A Systematic Review of Existing Approaches [0.03%]
HTA评估的医疗器械遴选和优先级划分：现有方法的系统综述
João Félix Pimenta,Ana C L Vieira
João Félix Pimenta
Background: Efficient resource allocation in the health technology assessment process of medical devices requires a robust selection and prioritization of medical devices for evaluation. Despite its importance, there is c...
Correction: Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England [0.03%]
关于新型抗菌药物价值评估的更正：评价头孢狄洛和头孢他啶-阿维巴坦，为英格兰NHS去关联支付提供信息
Beth Woods,Ben Kearns,Laetitia Schmitt et al.
Beth Woods et al.
Published Erratum
Applied health economics and health policy. 2025 Jun 2. DOI:10.1007/s40258-025-00979-4 2025
The Cost-Effectiveness of Initiating Patients on Home Dialysis Compared with In-Centre Haemodialysis [0.03%]
家中透析与中心透析的起始成本效益分析比较研究
Harry Hill,James Fotheringham,Jessica Potts et al.
Harry Hill et al.
Objectives: Kidney failure can be treated at home with peritoneal dialysis or home haemodialysis. The combination of reduced staffing, transport and overhead costs and improved quality of life through treatment at home co...
Using a Markov Model and Real-World Evidence to Identify the Most Cost-Effective Cholesterol Treatment Escalation Threshold for the Secondary Prevention of Cardiovascular Disease [0.03%]
使用马尔可夫模型和现实世界证据识别二次预防心血管疾病的最具有成本效益的胆固醇治疗升级阈值
Alfredo Mariani,Syed Mohiuddin,Patrick Muller et al.
Alfredo Mariani et al.
Background: Despite the decreased risk of cardiovascular disease (CVD) with statins, there remains an unfulfilled clinical need to prevent CVD events and premature mortality through further cholesterol-modifying intervent...
Authors' Reply to Sadia Farhana's Comment on: "Comparison of Caregiver and General Population Preferences for Dependency-Related Health States" [0.03%]
关于“照护者和普通人群对依赖相关健康状态的偏好比较”的作者回信答复Sadia Farhana的评论
Eva Rodríguez-Míguez,Antonio Sampayo
Eva Rodríguez-Míguez
Antimicrobial Resistance (AMR) Development Map: A Conceptual Map and a Tool to Support Economic Evaluation of AMR Interventions [0.03%]
抗菌药物耐药性（AMR）发展地图：一个概念图和支撑AMR干预措施经济评价的工具
Kristina Aluzaite,Marta O Soares,Catherine Hewitt et al.
Kristina Aluzaite et al.
Introduction: Antimicrobial resistance (AMR) is a complex, inter-sectoral and international problem. Economic evaluation (EE) methods offer systematic, evidence-driven approaches to inform policy decisions about which AMR...